Close Menu

Molecular Health

Increasing activity from sequencing vendors and other new players, as well as a flurry of activity around clinical data analysis software and the commercialization of a number of open source tools were the key trends in the bioinformatics community in 2012.

MolecularHealth is working with SAP to help it speed up a software solution it is developing to help oncologists make better treatment decisions for their patients.

People in the News: Larry Lesko

Premium

Lawrence Lesko, former director of the Office of Clinical Pharmacology at the US Food and Drug Administration’s Center for Drug Evaluation and Research, has joined MolecularHealth as a scientific advisor.

MolecularHealth said this week that it has signed a five-year agreement with the US Food and Drug Administration under which the agency will "evaluate and refine" it's Molecular Analysis of Side Effects, or MASE, software, which supports mechanism-based drug safety assessment and

Pages

The former commissioner of the FDA has returned to the venture capital firm New Enterprise Associates as a special partner on the healthcare investment team.

Astronauts have edited yeast genes on the International Space Station in an experiment designed to show how cells repair themselves in space.

Emory University has found that two of its researchers failed to divulge they had received funds from China, according to the Atlanta Journal-Constitution.

In Science this week: influence of the nuclear genome on human mitochondrial DNA, and more.